Trifluridine is capable of inducing DRS in cells, leading to the accumulation of S-phase cells and the activation of the p53-p21 pathway, which in turn promotes cellular senescence and inhibits tumor cell growth (64). The gene discussed is CDKN1A; the disease is neoplasm.